← Back to Search
Scleroderma Registry & Repository At the Hospital for Special Surgery
New York, NY
N/A
Recruiting
Led By Robert F Spiera, MD
Research Sponsored by Hospital for Special Surgery, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Individuals older than 18 years of age with Scleroderma
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline & follow-up visits during regularly scheduled appointments for up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is for a potential treatment for Scleroderma, a currently untreatable condition.
See full description
Eligible Conditions
- Scleroderma
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
* Individuals older than 18 years of age with Scleroderma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline & follow-up visits during regularly scheduled appointments for up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline & follow-up visits during regularly scheduled appointments for up to 5 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Modified Rodnan Skin Score
Secondary study objectives
Scleroderma Health Assessment Questionnaire
Short Form-36
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Find a Location
Closest Location:Hospital for Special Surgery· New York, NY· 480 miles
Who is running the clinical trial?
Hospital for Special Surgery, New YorkLead Sponsor
252 Previous Clinical Trials
60,943 Total Patients Enrolled
Robert F Spiera, MDPrincipal InvestigatorHospital for Special Surgery, New York
2 Previous Clinical Trials
13 Total Patients Enrolled
Jessica K Gordon, MDPrincipal InvestigatorHospital for Special Surgery, New York